Search

everythinglearnresearchcommunity

for

Search:↓

Both Platelet-Rich Plasma and Minoxidil foam increase hair count in women with hair loss, but Minoxidil is more effective. However, women were more satisfied with Platelet-Rich Plasma treatment.

Facial aging is caused by natural processes and external factors, and can be managed with preventative measures and a variety of treatments tailored to individual needs.

Gemcitabine and paclitaxel are effective and safe as first-line treatment for metastatic breast cancer.

Birth control pills help treat skin and hair growth problems linked to high male hormone levels.

Transgender patients need proper skin care, especially when undergoing hormone treatments, to manage issues like acne and hair loss.

The review highlights the need for more research on transgender dermatology, the role of dermatologists in gender affirmation, and the effects of hormone therapy on skin and hair.

Topical minoxidil helps treat female pattern hair loss, but more research needed for other treatments.

Cross-sex hormone therapy is important for managing gender dysphoria and requires careful monitoring and healthcare provider education.

Treat adult facial vascular anomalies with lasers, surgery, or observation, depending on the patient's specific condition.

Hair growth is influenced by factors like genetics and nutrition, and more research is needed to understand hair loss and growth mechanisms.

Androgen excess disorders in women were effectively treated with spironolactone, estrogen, and dexamethasone.

The document concludes that managing side effects of MS therapies is crucial for treatment success and patient adherence.

Selective Androgen Receptor Modulators (SARMs) are drugs that can control the effects of androgens in different tissues, potentially having fewer side effects and promising for treating various conditions.

Women experience various skin issues at different life stages, requiring careful treatment and awareness.

Low testosterone in men is a risk factor for a specific heart rhythm issue, and testosterone treatment may help prevent it.

The document concludes that non-operative treatment for gender dysphoria is safe and effective, and hormone therapy does not increase cancer risk.

Different treatments for alopecia areata have unpredictable results and varying success rates.

DHT is a strong androgen that may pose less risk to the prostate compared to testosterone.

New compounds can block testosterone effects in rats and might help treat conditions like prostate cancer and acne.

Minoxidil and finasteride work best for hair loss; more research needed.

Finasteride effectively treats central serous chorioretinopathy.

Patients with schizophrenia have a high rate of skin diseases, with fungal infections and dermatitis being most common, and those on clozapine have a lower risk of fungal infections.

The document concludes that various cosmetic and drug treatments are available for hirsutism, and some new drugs show promise.

Hair can indicate early signs of metabolic disorders, with issues like protein deficiency stopping hair growth.

Experts agreed on guidelines to improve research on Frontal Fibrosing Alopecia.

Advanced therapies like gene, cell, and tissue engineering show promise for hair regrowth in alopecia, but their safety and effectiveness need more verification.

Various treatments, including FDA-approved drugs, natural products, and oral supplements, can help with hair loss, but a patient's medical history and potential allergies should be considered when choosing a treatment.

PRP did not significantly regrow hair in alopecia areata totalis patients.

Some treatments can stabilize Frontal Fibrosing Alopecia, but more research is needed to find effective treatments, and hair transplants often fail.

Liposomes improve the delivery and effectiveness of cosmetic ingredients but face challenges like cost and stability.